A detailed history of Utah Retirement Systems transactions in Royalty Pharma PLC stock. As of the latest transaction made, Utah Retirement Systems holds 64,600 shares of RPRX stock, worth $1.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
64,600
Previous 64,100 0.78%
Holding current value
$1.82 Million
Previous $1.95 Million 12.49%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$26.26 - $29.9 $13,130 - $14,950
500 Added 0.78%
64,600 $1.7 Million
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $2,746 - $3,133
-100 Reduced 0.16%
64,100 $1.95 Million
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $10,484 - $11,688
400 Added 0.63%
64,200 $1.8 Million
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $5,252 - $6,276
200 Added 0.31%
63,800 $1.73 Million
Q2 2023

Aug 14, 2023

SELL
$29.6 - $36.56 $79,920 - $98,712
-2,700 Reduced 4.07%
63,600 $1.96 Million
Q4 2022

Feb 15, 2023

BUY
$39.17 - $44.04 $23,502 - $26,424
600 Added 0.91%
66,300 $2.62 Million
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $7,976 - $8,930
200 Added 0.31%
65,700 $2.64 Million
Q2 2022

Aug 16, 2022

BUY
$37.53 - $44.22 $281,475 - $331,650
7,500 Added 12.93%
65,500 $2.75 Million
Q1 2022

May 13, 2022

SELL
$37.46 - $42.44 $37,460 - $42,440
-1,000 Reduced 1.69%
58,000 $2.26 Million
Q4 2021

Feb 14, 2022

BUY
$35.17 - $42.48 $7,034 - $8,496
200 Added 0.34%
59,000 $2.35 Million
Q3 2021

Nov 16, 2021

SELL
$36.14 - $42.24 $101,192 - $118,272
-2,800 Reduced 4.55%
58,800 $2.13 Million
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $7,970 - $9,326
200 Added 0.33%
61,600 $2.53 Million
Q1 2021

May 17, 2021

BUY
$42.34 - $52.82 $1.71 Million - $2.13 Million
40,300 Added 191.0%
61,400 $2.68 Million
Q4 2020

Feb 16, 2021

BUY
$36.12 - $50.05 $762,132 - $1.06 Million
21,100 New
21,100 $1.06 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $12.3B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.